3-[(17Z)-13,14-Dihydroxy-17-triaconten-1-yl]-5-methyl-2(5H)-furanone

Metabolite details

Identifier

GFUJWCRMULHYHE-QOCHGBHMSA-N

InChI Key

GFUJWCRMULHYHE-QOCHGBHMSA-N

IUPAC name

4-[(Z)-13,14-dihydroxytriacont-17-enyl]-2-methyl-2H-uran-5-one

Preferred name

3-[(17Z)-13,14-Dihydroxy-17-triaconten-1-yl]-5-methyl-2(5H)-furanone

INN name

—

Synonym

—

ChEBI

CHEBI:176705

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Metabolic Dynamics of In Vitro CD8+ T Cell Activation.
• Global analysis of plasma lipidomics reveals altered lipid signatures in patients with osteonecrosis of the femoral head
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• Unraveling the metabolic effects of benzophenone-3 on the endosymbiotic dinoflagellate Cladocopium goreaui

Observed in differential profiles

• G3_Experimental_Sample_0h_vs_G11_Experimental_Sample_96h
• Control_vs_AONFH_Stage_III_IV
• wild_type_vs_patA_deletion
• Control_vs_BP3_Low_Concentration